Veracyte Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Veracyte, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue445.76361.05296.54219.51117.48120.3792.01
Cost of Revenue147.62131.37120.8674.4041.46-36.0833.08
Gross Profit298.15229.68175.68145.11117.48120.3758.93
Operating Expenses
Research & Development69.2957.3140.6029.8417.2014.8514.82
Selling, General & Administrative206.04187.72170.76180.3889.12118.8065.28
Operating Expenses278.14246.56211.02226.21147.33135.0581.16
Operating Income20.01-16.88-35.34-81.09-35.39-15.13-22.23
Other Income/Expense
Interest Income11.157.341.970.140.590.000.00
Interest Expense0.000.020.20-0.24-0.230.001.96
Other Income/Expense-5.41-67.07-2.861.44-0.48-3.211.20
Income
Income Before Tax25.74-76.61-36.43-81.65-34.91-12.60-23.00
Income Tax Expense1.61-2.210.13-6.09-1.79-0.830.00
Net Income24.14-74.40-36.56-75.56-34.91-12.60-23.00
Net Income - Continuous Operations24.14-74.40-36.56-75.560.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA49.21-49.41-10.30-61.50-26.74-7.39-17.12
EBIT25.75-76.60-36.23-81.09-34.68-11.59-21.04
Depreciation & Amortization3.302.112.0819.595.101.401.07
Earnings Per Share
Basic EPS--1.00-1.00-1.00-1.00--1.00
Diluted EPS--1.00-1.00-1.00-1.00--1.00
Basic Shares Outstanding76.4872.6471.5567.8953.2446.1437.02
Diluted Shares Outstanding78.1672.6471.5567.8952.8946.6637.02